The Latest Breaking News from FDA

There are other pills that patients can add to their statin

Supplements are intended to boost health, but a recent multi-state Salmonella outbreak in 2026 has turned morning wellness routines into a significant risk. Two major “superfood” brands are currently at the center of a federal investigation. The FDA and CDC are tracking at least 65 illnesses across 28 states, with…

Your morning hygiene routine is supposed to be the simplest part of your day. You reach for the bottle, rinse, and go. But a massive new recall of over 80,000 bottles of Parodontax Active Gum Health mouthwash has turned a basic habit into a potential risk. The FDA has issued…

A simple sandwich shouldn’t be a gamble with your life, but for residents in nine states, the pantry staple in their kitchen could be a ticking time bomb. The FDA has issued a frantic update after a third-party distributor accidentally shipped thousands of cans of recalled Genova Yellowfin Tuna that…

A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed to drastically shorten the review of certain drugs

MoonLake shares are rallying after the FDA granted Fast Track designation for its lead drug and cleared the path for a major filing later this year.

It seems likely the FDA would do well to accept more Bayesian reasoning in medical research.

Erasca (ERAS) has surged 460% over the past year, driven by strong technical momentum. ERAS hit a new 3-year high of $10.92 on Monday. Despite bullish technicals, ERAS has no revenue, is burning cash, and its future hinges on FDA drug approvals. Analyst sentiment is highly speculative, with price targets...

You trust that the pill bottle you pick up from the pharmacy is safe. You assume there are rigorous checks and balances before that medication reaches your hands. Unfortunately, the reality of the global pharmaceutical supply chain is far messier. Recently, the FDA issued a recall for the popular blood-pressure…

Novo Nordisk, the Danish manufacturer of weight-loss drugs Ozempic and Wegovy, has a large market share in the US. But it's not enough to put pressure on US President Donald Trump's administration during Greenland talks, experts say.

We treat our pets like family, often buying the most expensive “premium” food to ensure their health. But a disturbing standoff is currently unfolding between federal regulators and a well-known boutique dog food manufacturer.